Glenmark Pharmaceuticals gets final approval for Nystatin and Triamcinolone Acetonide Cream
From USFDA
Glenmark Pharmaceuticals has been granted final approval by the USFDA for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g, the generic version of Mycolog-II Cream, 100,000 units/g, 0.1% of Delcor Asset Corporation (which is no longer being marketed in the United States).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content